Natixis Procept Bio Robotics Corp Transaction History

Natixis

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$24.89 - $43.41 $763,276 - $1.33 Million	30,666 Added 4761.8%	31,310 $1.31 Million
Q3 2023 Nov 14, 2023	SELL	$30.02 - $38.81 $1.33 Million - $1.72 Million	-44,258 Reduced 98.57%	644 $21,000
Q2 2023 Aug 11, 2023	SELL	$26.7 - $37.02 $6,781 - $9,403	-254 Reduced 0.56%	44,902 $1.59 Million
Q1 2023 May 12, 2023	SELL	$26.64 - $39.74 $1.27 Million - $1.9 Million	-47,848 Reduced 51.45%	45,156 $1.28 Million
Q4 2022 Feb 24, 2023	BUY	$38.78 - $46.78 $1.8 Million - $2.18 Million	46,502 Added 100.0%	93,004 $3.86 Million
Q4 2022 Feb 13, 2023	SELL	$38.78 - $46.78 $64,762 - $78,122	-1,670 Reduced 3.47%	46,502 $1.93 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $683,322 - $1.12 Million	22,114 Added 84.86%	48,172 $2.03 Million
Q2 2022 Aug 12, 2022	BUY	$29.23 - $44.45 $761,675 - $1.16 Million	26,058 New	26,058 $862,000

295

41.6M

196K

141K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $2.66B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.